399 related articles for article (PubMed ID: 11511021)
1. The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma.
McCloskey EV; Guest JF; Kanis JA
Drugs; 2001; 61(9):1253-74. PubMed ID: 11511021
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the role of bisphosphonates in metastatic disease.
Ross JR; Saunders Y; Edmonds PM; Patel S; Wonderling D; Normand C; Broadley K
Health Technol Assess; 2004; 8(4):1-176. PubMed ID: 14960258
[TBL] [Abstract][Full Text] [Related]
5. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost of bisphosphonate therapy in tumor bone disease.
Body JJ
Cancer; 2003 Feb; 97(3 Suppl):859-65. PubMed ID: 12548587
[TBL] [Abstract][Full Text] [Related]
7. The role of bisphosphonates in breast and prostate cancers.
Brown JE; Neville-Webbe H; Coleman RE
Endocr Relat Cancer; 2004 Jun; 11(2):207-24. PubMed ID: 15163299
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid: a review of its use in patients with advanced cancer.
Perry CM; Figgitt DP
Drugs; 2004; 64(11):1197-211. PubMed ID: 15161327
[TBL] [Abstract][Full Text] [Related]
10. [Bisphosphonates and bone metastases].
Lortholary A; Jadaud E; Berthaud P
Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
[TBL] [Abstract][Full Text] [Related]
11. The future of bisphosphonates in cancer.
Coleman RE; Purohit OP; Vinholes JJ
Acta Oncol; 1996; 35 Suppl 5():23-9. PubMed ID: 9142961
[TBL] [Abstract][Full Text] [Related]
12. The use of bisphosphonates in patients with breast cancer.
Van Poznak CH
Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate therapy in multiple myeloma: past, present, future.
Jantunen E
Eur J Haematol; 2002; 69(5-6):257-64. PubMed ID: 12460229
[TBL] [Abstract][Full Text] [Related]
14. Should bisphosphonates be the treatment of choice for metastatic bone disease?
Coleman RE
Semin Oncol; 2001 Aug; 28(4 Suppl 11):35-41. PubMed ID: 11544574
[TBL] [Abstract][Full Text] [Related]
15. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates: clinical experience.
Coleman RE
Oncologist; 2004; 9 Suppl 4():14-27. PubMed ID: 15459426
[TBL] [Abstract][Full Text] [Related]
17. The role of bisphosphonates in breast cancer management: review article.
Pickering LM; Mansi JL
Curr Med Res Opin; 2002; 18(5):284-95. PubMed ID: 12240791
[TBL] [Abstract][Full Text] [Related]
18. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
[TBL] [Abstract][Full Text] [Related]
19. Prevention of bone metastases from breast cancer by adjuvant bisphosphonate therapy.
Kohno N; Kokufu I
Breast Cancer; 2003; 10(1):33-7. PubMed ID: 12525761
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates in the treatment of metastatic breast cancer.
Body JJ
J Mammary Gland Biol Neoplasia; 2001 Oct; 6(4):477-85. PubMed ID: 12013536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]